Showing results (221-230 of 710) with videos related to
Sort By:
Pageof 71
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 5, 2017
The Role of Immune Checkpoint Inhibition in the Treatment of Brain TumorsAndrew S Luksik, Russell Maxwell, Tomas Garzon-Muvdi, et al.Journal of Hazardous Materials|April 28, 2015
Potential explosion hazard of carbonaceous nanoparticles: Explosion parameters of selected materialsLeonid A Turkevich, Ashok G Dastidar, Zachary Hachmeister, et al.Journal of Neuro-Oncology|April 17, 2015
Combining immunotherapy with radiation for the treatment of glioblastomaKevin K H Chow, Wendy Hara, Michael Lim, et al.Neurosurgery Clinics of North America|July 4, 2012
Immunotherapy for glioma: promises and challengesSeunggu J Han, Corinna Zygourakis, Michael Lim, et al.Operative Neurosurgery (Hagerstown, Md.)|December 20, 2019
Natural History of Untreated Transverse/Sigmoid Sinus Thrombosis Following Posterior Fossa Surgery: Case Series and Literature ReviewAlon Orlev, Christopher M Jackson, Andrew Luksik, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2016
Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC)Anna E Prizment, Amy M Linabery, Pamela L Lutsey, et al.Operative Neurosurgery (Hagerstown, Md.)|November 25, 2024
Open Microsurgical Versus Endovascular Management of Unruptured and Ruptured Brain AneurysmsJennifer E Kim, Risheng Xu, Christopher M Jackson, et al.Cancer Causes & Control : CCC|February 6, 2010
Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studiesElizabeth A Platz, Siobhan Sutcliffe, Angelo M De Marzo, et al.International Journal of Cancer|February 5, 2015
Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up StudyElizabeth A Platz, Charles G Drake, Kathryn M Wilson, et al.Biorxiv : the Preprint Server for Biology|January 30, 2023
KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy responseCasey R Ager, Mingxuan Zhang, Matthew Chaimowitz, et al.Pageof 71